Usefulness of 201Tl spect/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma

Head and Neck

Volumn 31, Issue 6, 2009, Pages 717-724

  Yen, Ruoh Fang ^a   Ting, Lai Lei ^a   Cheng, Mei Fang ^a   Wu, Yen Wen ^a   Tzen, Kai Yuan ^a   Hong, Ruey Long ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

18F FDG PET CT; 201Tl SPECT CT; Nasopharyngeal carcinoma; Recurrence; Skull base

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; MITOMYCIN; THALLIUM CHLORIDE TL 201; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; NASOPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKULL BASE; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY; PREDICTION AND FORECASTING; PROBABILITY; PROSPECTIVE STUDY; ROC CURVE; SCINTISCANNING; STATISTICAL MODEL; TUMOR RECURRENCE;

ADULT; AGED; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LOGISTIC MODELS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SKULL BASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 67049132789     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21026     Document Type: Article

References (28)

1. Huang DP. Epidemiology of nasopharyngeal carcinoma. Ear Nose Throat J 1990;69:222-225. (Pubitemid 20192716)
2. Cheng SH, Jian JJ, Tsai SY, et al. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 2000;48:1323-1330.
3. Cheng SH, Tsai SY, Yen KL, et al. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma. J Clin Oncol 2000;18:2040-2045. (Pubitemid 30324356)
4. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy verus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-1317. (Pubitemid 28175745)
5. Oh JL, Vokes EE, Kies MS, et al. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol 2003;14:564-569. (Pubitemid 41295084)
6. Rischin D, Corry J, Smith J, et al. Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation. J Clin Oncol 2002;20:1845-1852. (Pubitemid 34273275)
7. Hong RL, Ting LL, Ko JY, et al. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 2001;19:4305-4313. (Pubitemid 33096778)
8. Baker SR, Wolfe RA. Prognostic factors of nasopharyngeal malignancy. Cancer 1982;49:163-169. (Pubitemid 12196152)
9. Liu MT, Hsieh CY, Chang TH, et al. Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol 2003;33:501-508. (Pubitemid 43115242)
10. Farias TP, Dias FL, Lima RA, et al. Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2003;129:794-799. (Pubitemid 36858970)
11. Chong VF, Fan YF. Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 1997;202:463-470. (Pubitemid 27051744)
12. Ng SH, Chang JT, Ko SF, et al. MRI in recurrent nasopharyngeal carcinoma. Neuroradiology 1999;41:855-862.
13. Olmi P, Fallai C, Colagrande S, Giannardi G. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int J Radiat Oncol Biol Phys 1995;32:795-800.
14. Kao CH, ChangLai SP, Chieng PU, Yen RF, Yen TC. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 1998;16:3550-3555. (Pubitemid 28506767)
15. Yen RF, Hung RL, Pan MH, et al. 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer 2003;98:283-287. (Pubitemid 36828451)
16. 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma. J Nucl Med 2005;46:770-774.
17. Fischbein NJ, AAssar OS, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol 1998;19:1189-1196. (Pubitemid 30418656)
18. Hung GU, Tsai SC, Lin WY. Extraordinarily high F-18 FDG uptake caused by radiation necrosis in a patient with nasopharyngeal carcinoma. Clin Nucl Med 2005;30:558-559. (Pubitemid 41026203)
19. Liu SH, Chang JT, Ng SH, Chan SC, Yen TC. False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecorsis in a nasopharyngeal carcinoma patient. Br J Radiol 2004;77:257-260. (Pubitemid 38404797)
20. Siepmann DB, Siegel A, Lewis PJ. Tl-201 SPECT and F-18 FDG PET for assessment of glioma recurrence versus radiation necrosis. Clin Nucl Med 2005;30:199-200. (Pubitemid 40270974)
21. 201Tl uptake in tumours. Eur J Nucl Med 1989;15:376-379.
22. Waxman AD. Thallium-201 in nuclear oncology. In: Freeman LM, editor. Nuclear medicine annual 1991. New York: Raven Press; 1991. pp 193-197.
23. Elgazzar AH, Fernandez-Ulloa M, Silberstein EB. 201Tl as a tumour-localizing agent: current status and future considerations. Nucl Med Commun 1993;14:96-103. (Pubitemid 23069361)
24. Vos MJ, Hoekstra OS, Barkhof F, et al. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma. J Clin Oncol 2003;19:3559-3565. (Pubitemid 46594046)
25. Schillaci O, Danieli R, Manni C, Simonetti G. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun 2004;25:705-710.
26. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231:65-72. (Pubitemid 38375411)
27. Fischer BM, Olsen MW, Ley CD, et al. How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study. Eur J Nucl Med Mol Imaging 2006;33:697-702. (Pubitemid 43846761)
28. Dierckx RA, Martin JJ, Dobbeleir A, et al. Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994;21:621-633. (Pubitemid 24211114)